Overview

AKL 1 Asthma Study

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
This study aims to provide scientific evidence of the efficacy and safety of this agent as 'add-on' therapy for adult patients whose asthma remains uncontrolled on standard medication. The aims are to assess the efficacy, safety and tolerability of AKL 1 companred to placebo in the treatment of asthma.
Phase:
Phase 2
Details
Lead Sponsor:
University of Aberdeen